0

Total Occlusion Late after Myocardial Infarction

Click below to access your content. Note you must complete both the course content and the evaluation survey in order to claim your certificate. When you have completed the course content, please return to this page and click on the Claim Survey link below to access your certificate. Once you have successfully completed this course your certificate will become available at the top of this page and on your My Certificates page.

Course Details

Credit/contact hours: .25
Estimated time to complete: 15 minutes
Publication Date: May 10, 2018
Expiration date: May 9, 2021
Reviewed:

Description:

It is well established the prompt reperfusion therapy within the first six hours of MI symptom onset can significantly reduce mortality and morbidity after MI, and reperfusion therapy with PCI/stenting or fibrinolysis is well established. However, it is not uncommon that a patient will undergo coronary angiography 12 or even 24 hours after MI, where a totally occluded artery is identified at that point in time. We present a case of such a patient and review a classic clinical trial that addresses this clinical situation.

You Will Learn

  • To identify patients who present at later time points when reperfusion therapy is less well established
  • To enumerate patient-specific considerations when considering PCI in patients presenting late after MI
  • To appropriately apply the results of a classic clinical trial relating to this situation
  • To consider the appropriate clinical guidelines as they apply to patients presenting late after MI

Method and medium:

Learners participate in the interactive learning modules by correctly answering multiple choice questions dispersed throughout. Learners will be prompted to try again if a question is answered incorrectly.The course will open in a new tab - to exit the course, simply close that tab.

Lawrence W Gimple, MD

Dr. Gimple is an attending cardiologist at the University of Virginia Health System with a sub-specialty in interventional cardiology.  He serves as the Director of Clinical Cardiology at the University of Virginia Health System with clinical interests in coronary artery disease, coronary stenting, and heart attack.

DISCLOSURE: This individual reports no relevant financial relationships with commercial entities.

Please rate this


 5/5 (1)